4 Results for "

B-RafWT

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "B-RafWT" in MCE Product Catalog:

  • Isoforms Recommended:
Cat. No.: HY-137487
CAS No.: 2417296-84-3
Pureté:  98.02%
Target:  

PROTACs Raf

Domaines de recherche:  

Cancer

PROTAC BRAF-V600E degrader-1 (compound 23) is a potent PROTAC BRAF-V600E degrader whlie no degradation activity against BRAF-WT. PROTAC BRAF-V600E degrader-1 exhibits Kd values of 2.4 nM and 2 nM for BRAF and BRAF-V600E, respectively. PROTAC BRAF-V600E degrader-1 degrades BRAF-V600E via the ubiquitin-proteasome system (UPS) and inhibits the growth of melanoma cells .
loading...
    loading...
Cat. No.: HY-77113
CAS No.: 918504-27-5
Target:  

Raf

Domaines de recherche:  

Cancer

B-Raf IN 11 is a B-Raf V600E mutant kinase inhibitor with an IC50 of 76 nM, and exhibits an IC50 of 238 nM against wild-type B-Raf kinase. B-Raf IN 11 inhibits the kinase activities of B-Raf V600E mutant and wild-type B-Raf kinase. B-Raf IN 11 is applicable to relevant research on colorectal cancer .
loading...
    loading...
Cat. No.: HY-155942
CAS No.: 708218-62-6
Target:  

p38 MAPK Raf

Domaines de recherche:  

Cancer

B-Raf IN 19 (compound 31) is a BRAF inhibitor that inhibits BRAF(WT) and BRAF(V600E) (IC50: 0.57 μM and 0.28 μM, respectively). B-Raf IN 19 inhibits MAPK signaling in melanoma cells .
loading...
    loading...
Cat. No.: HY-158027
Target:  

Raf VEGFR FGFR

Domaines de recherche:  

Cancer

B-Raf IN 17 (Compound 8e) is a potent and orally active type II multi-kinase inhibitor. B-Raf IN 17 exhibits potent cellular-level suppression of BRAFWT, VEGFR-2, and FGFR-1 in A375 cell line, with IC50 values of 0.02, 0.18 and 1.65 μM, respectively. B-Raf IN 17 can be used for the research of cancer .
loading...
    loading...